Patent · US Active

Cyclic peptides multimers targeting α4β7 integrin

US12077611B2 · kind B2 · utility

0Cited by
15References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2023
Grant dateSep 3, 2024
Priority date
Expiry dateJun 8, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is described herein, multimers comprising a plurality of compounds covalently linked together, the compounds independently being of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.